--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 12, 20242024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
Micron Technology
MU
NVIDIA
NVDA
Intel
INTC
Adobe
ADBE
Salesforce
CRM
US Stock MarketDetailed Quotes
NMRA Neumora Therapeutics
- 10.850
- +0.350+3.33%
Close Dec 20 16:00 ET
- 10.360
- -0.490-4.52%
Post 20:01 ET
1.75BMarket Cap9.77P/E (TTM)
11.100High10.073Low1.90MVolume10.170Open10.500Pre Close20.59MTurnover2.24%Turnover RatioLossP/E (Static)161.56MShares21.00052wk High5.47P/B921.38MFloat Cap8.33052wk Low--Dividend TTM84.92MShs Float21.000Historical High--Div YieldTTM9.78%Amplitude8.330Historical Low10.812Avg Price1Lot Size
Neumora Therapeutics Key Stats
Neumora Therapeutics Q3 2024 Earnings Date
Currency：USDNov 12, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 0 | 0 | 0 |
-- | -- | -- | |
| EPS | -0.39 | -0.45 | -0.06 |
| Miss Est. | +65.78% | +60.53% | -15.36% |
Analyst Rating
Nov 30, 2024
Neumora Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Neumora Therapeutics Earnings Reports
Read more
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data